SINTRA-REV CLINICAL TRIAL: PRELIMINARY ANALYSIS OF EFFICACY AND SAFETY AT WEEK 12 OF TREATMENT IN MDS DEL(5Q) AND TRANSFUSION INDEPENDENCE

被引：0

作者：

Lopez Cadenas, F. ^{[1
]}

Xicoy, B. ^{[2
]}

Sanchez, J. ^{[3
]}

Fenaux, P. ^{[4
]}

Hernandez Rivas, J. A. ^{[5
]}

Amigo, M. L. ^{[6
]}

Coll, R. ^{[7
]}

Lumbreras, E. ^{[8
]}

Slama, B. ^{[9
]}

Bernal, T. ^{[10
]}

De Paz, R. ^{[11
]}

Platzbecker, U. ^{[12
]}

Giagounidis, A. ^{[13
]}

Nomdedeu, B. ^{[14
]}

Thepot, S. ^{[15
]}

Sanz, G. ^{[16
]}

Arrizabalaga, B. ^{[17
]}

Bargay, J. ^{[18
]}

Del Canizo Fernandez-Roldan, M. C. ^{[1
]}

Diez-Campelo, M. ^{[1
]}

机构：

[1] Complejo Asistencial Univ Salamanca, Hematol, Salamanca, Spain

[2] Ico Badalona Hosp Univ Germans Trias & Pujol, Hematol, Barcelona, Spain

[3] Hosp Reina Sofia Cordoba, Hematol, Cordoba, Spain

[4] Hop St Louis, Hematol, Paris, France

[5] Hosp Univ Infanta Leonor, Hematol, Madrid, Spain

[6] Hosp Univ Morales Meseguer, Hematol, Murcia, Spain

[7] Ico Girona Hosp Josep Trueta, Hematol, Girona, Spain

[8] Univ Salamanca, CSIC, Ctr Invest Canc, Unidad Diagnost Mol & Celular Canc,Ibsal, Salamanca, Spain

[9] Ctr Hosp Avignon, Hematol, Avignon, France

[10] Hosp Cent Asturias, Hematol, Oviedo, Spain

[11] Hosp La Paz, Hematol, Madrid, Spain

[12] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Hematol, Dresden, Germany

[13] Marien Hosp, Hematol, Dusseldorf, Germany

[14] Hosp Clin Barcelona, Hematol, Barcelona, Spain

[15] Ctr Hosp Univ Angers, Hematol, Angers, France

[16] Hosp Univ & Politecn La Fe, Hematol, Valencia, Spain

[17] Hosp Cruces, Hematol, Bilbao, Spain

[18] Hosp Son Llatzer, Hematol, Palma De Mallorca, Spain

来源：

LEUKEMIA RESEARCH | 2017年 / 55卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S52 / S52

页数：1

共 46 条

[1] PRELIMINARY ANALYSIS OF EFFICACY AND SAFETY OF SINTRA-REV CLINICAL TRIAL, LENALIDOMIDE VS PLACEBO PHASE 3 STUDY IN LOW/INT-1 MDS PATIENTS WITH DEL(5Q) AND TRANSFUSION INDEPENDENCY
Lopez Cadenas, F.
Xicoy, B.
Bargay, J.
Sanz, G.
Amigo, M. L.
Arrizabalaga, B.
Bernal, T.
De Paz, R.
Sanchez, J.
Nomdedeu, B.
Hernandez Rivas, J. A.
Fenaux, P.
Slama, B.
Giagounidis, A.
Lumbreras, E.
Thepot, S.
Platzbecker, U.
Coll, R.
Redondo, A.
Fernandez Roldan, M. C. Del Canizo
Diez-Campelo, M.
HAEMATOLOGICA, 2017, 102 : 484 - 485
[2] Phase 3 Study of Lenalidomide Vs Placebo in Non-Transfusion Dependent Low Risk MDS Del(5q) Patients: Preliminary Blinded Analysis of the European SINTRA-REV Trial
不详
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (02) : 14 - 15
[3] Phase 3 Study of Lenalidomide vs Placebo in Non-Transfusion Dependent Low Risk del(5q) MDS Patients - Interim Analysis of the European Sintra-REV Trial
不详
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (01) : 17 - 18
[4] Long-Term Evolution of Somatic Mutations in Patients with Del(5q) MDS Early Treated with Lenalidomide in the Sintra-Rev Clinical Trial: Safe and Effecitive Approach?
Toribio Castello, Sofia M.
Lopez-Cadenas, Felix
Preudhomme, Claude
Villaverde Ramiro, Angela
Fenwarth, Laurene
Lumbreras, Eva
Gonzalez, Teresa
Del Rey, Monica
Xicoy, Blanca
Renneville, Aline
Sanchez-Garcia, Joaquin
Coll, Rosa
Slama, Bohrane
Angel Hernandez-Rivas, Jose
Thepot, Sylvain
Bernal, Teresa
Guerci-Bresler, Agnes
Gotze, Katharina
Maria Hernandez-Rivas, Jesus
Fenaux, Pierre
Del Canizo, Consuelo
Diez-Campelo, Maria
BLOOD, 2022, 140 : 9740 - 9743
[5] Phase 3 Study of Lenalidomide (LEN) Vs Placebo in Non-Transfusion Dependent (TD) Low Risk Del(5q) - Preliminary Blinded Analysis of the European Sintra-REV Trial
Lopez Cadenas, Felix
Lumbreras, Eva
Xicoy, Blanca
Sanchez-Garcia, Joaquin
Fenaux, Pierre
Coll, Rosa
Slama, Borhane
Angel Hernandez-Rivas, Jose
Thepot, Sylvain
Bernal, Teresa
Arrizabalaga, Beatriz
Guerci, Agnes
Sanz, Guillermo
Bargay, Joan
Luz Amigo, Maria
de Paz, Raquel
Giagounidis, Aristoteles
Platzbecker, Uwe
Nomdedeu, Benet
Jourdan, Eric
Goetze, Katharina S.
Arar, Ali
Maria Hernandez-Rivas, Jesus
Del Canizo, Consuelo
Diez-Campelo, Maria
BLOOD, 2018, 132
[6] Phase 3 Study of Lenalidomide (LEN) Vs Placebo in Non-Transfusion Dependent (TD) Low Risk Del(5q) MDS Patients - Interim Analysis of the European Sintra-REV Trial
Cadenas, Felix Lopez
Lumbreras, Eva
Xicoy, Blanca
Sanchez, Joaquin
Coll, Rosa
Slama, Bohrane
Hernandez-Rivas, Jose Angel
Thepot, Sylvain
Bernal, Teresa
Arrizabalaga, Beatriz
Guerci-Bresler, Agnes
Sanz, Guillermo F.
Bargay, Joan
Amigo, Maria Luz
de Paz, Raquel
Nomdedeu, Benet
Giagounidis, Aristoteles
Platzbecker, Uwe
Wickenhauser, Stefan
Gotze, Katharina S.
Arar, Ali
Rivas, Jesus Maria Hernandez
Fenaux, Pierre
Del Canizo, Consuelo
Diez-Campelo, Maria
BLOOD, 2020, 136
[7] Evaluation of Lenalidomide (LEN) Vs Placebo in Non-Transfusion Dependent Low Risk Del(5q) MDS Patients. Final Results of Sintra-REV Phase III International Multicenter Clinical Trial
Lopez Cadenas, Felix
Lumbreras, Eva
Gonzalez, Teresa
Xicoy, Blanca
Sanchez-Garcia, Joaquin
Coll, Rosa
Slama, Bohrane
Angel Hernandez-Rivas, Jose
Thepot, Sylvain
Bernal, Teresa
Guerci-Bresler, Agnes
Sanz, Guillermo
Bargay, Joan
Luz Amigo, Maria
De Paz Arias, Raquel
Preudhomme, Claude
Giagounidis, Aristoteles
Platzbecker, Uwe
Wickenhauser, Stefan
Goetze, Katharina S.
Arar, Ali
Hernandez Rivas, Jesus M.
Toribio Castello, Sofia M.
Fenaux, Pierre
Del Canizo, Consuelo
Diez-Campelo, Maria
BLOOD, 2022, 140 : 1109 - 1111
[8] Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomide
Giagounidis, A. A. N.
Kulasekararaj, A.
Germing, U.
Radkowski, R.
Haase, S.
Petersen, P.
Goehring, G.
Buesche, G.
Aul, C.
Mufti, G. J.
Platzbecker, U.
LEUKEMIA, 2012, 26 (04) : 855 - 858
[9] Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomide
A A N Giagounidis
A Kulasekararaj
U Germing
R Radkowski
S Haase
P Petersen
G Göhring
G Büsche
C Aul
G J Mufti
U Platzbecker
Leukemia, 2012, 26 : 855 - 858
[10] Sequential Study By RNA-Seq Shows a Reduction in Inflammation and a Cell Cycle Activation in T-Lymphocytes from Myelodysplastic Syndrome with Del(5q) after Lenalidomide Treatment in Patients Included in the "Sintra-REV" Clinical Trial
Del Rey, Monica
Corchete, Luis A.
Gonzalez, Teresa
Cadenas, Felix Lopez
Lumbreras, Eva
Izquierdo, Marta Martin
Santos-Minguez, Sandra
Toribio, Sofia M.
Xicoy, Blanca
Sanchez-Garcia, Joaquin
Bernal, Teresa
Sanz, Guillermo F.
Nomdedeu, Benet
Fenaux, Pierre
Rivas, Jesus M. Hernandez
Diez-Campelo, Maria
BLOOD, 2020, 136

← 1 2 3 4 5 →